Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Exelixis, Inc.    EXEL

EXELIXIS, INC.

(EXEL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

EXELIXIS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
01/13/2020 | 04:31pm EDT

Item 2.02 Results of Operations and Financial Condition.

On January 12, 2020, Exelixis, Inc. ("Exelixis") issued a press release outlining its key priorities and anticipated milestones for 2020-21. The press release included preliminary (unaudited) financial results for the quarter and full year ended January 3, 2020. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The preliminary (unaudited) financial results contained in the press release do not present all information for an understanding of Exelixis' financial condition as of January 3, 2020 and its results of operations for the quarter and year ended January 3, 2020. The audit of Exelixis' financial statements for the year ended January 3, 2020 is ongoing and could result in changes to the information in the press release.

The information in this report, including the exhibit hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Exelixis, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.


(d)   Exhibits.
Exhibit
 Number      Exhibit Description
  99.1       Press Release issued
           January 12, 2020
101.INS    XBRL Instance Document     The instance document does not appear in the
                                      Interactive Data File because its XBRL tags
                                      are embedded within the Inline XBRL document.
101.SCH    Inline XBRL Taxonomy
           Extension Schema
           Document
101.CAL    Inline XBRL Taxonomy
           Extension Calculation
           Linkbase Document
101.DEF    Inline XBRL Taxonomy
           Extension Definition
           Linkbase Document
101.LAB    Inline XBRL Taxonomy
           Extension Labels
           Linkbase Document
101.PRE    Inline XBRL Taxonomy
           Extension Presentation
           Linkbase Document
  104      Cover Page Interactive     The cover page interactive data file does not
           Data File                  appear in the Interactive Data File because
                                      its XBRL tags are embedded within the Inline
                                      XBRL document.



--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on EXELIXIS, INC.
04/08EXELIXIS : to Webcast Virtual Fireside Chat as Part of the Needham Healthcare Co..
BU
03/25EXELIXIS : Announces Partner Takeda Receives Approval in Japan for CABOMETYX® (c..
BU
03/02EXELIXIS : Announces George A. Scangos, Ph.D. to Retire From Its Board of Direct..
BU
02/26EXELIXIS : Announces Webcasts of Investor Conference Presentations in March
BU
02/25EXELIXIS : 4Q Earnings Snapshot
AQ
02/25EXELIXIS, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
02/25EXELIXIS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
02/25EXELIXIS : Announces First 100 Patients Enrolled in Phase 3 COSMIC-311 Pivotal T..
BU
02/25EXELIXIS : Announces Fourth Quarter and Full Year 2019 Financial Results and Pro..
BU
02/21EXELIXIS, INC. : annual earnings release
More news